United States Platelet Rich Plasma Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

United States Platelet Rich Plasma Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Market Overview:

The United States platelet rich plasma market size reached US$ 226.7 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 403.9 Million by 2028, exhibiting a growth rate (CAGR) of 10% during 2023-2028.

Platelet-rich plasma (PRP) refers to a concentrated plasma protein that contains minor quantities of red blood cells. The platelets are suspended in a small amount of plasma after centrifugation and stimulate healing when injected into the body. PRP is widely administered by non-invasive therapies for long-lasting rejuvenation of ligaments and muscle fibers. Some of the common variants of PRP include pure platelet-rich plasma (P-PRP), leukocyte- and platelet-rich plasma (LPRP), leukocyte- and platelet-rich Fibrin (L-PRF), and pure platelet-rich fibrin (P-PRF).

The rising prevalence of chronic tendon injuries in vital organs is currently bolstering the demand for PRP-based therapies in the US. Furthermore, increasing adoption of effective therapies for treating muscle and acute ligament tearing, arthritis, fractures, orthopedic impairments, etc., is also propelling the market growth. In line with this, the growing awareness towards numerous benefits of PRP treatment in preventing inflammation, encouraging new cartilage formulation, and inducing natural lubrication fluid production, is further augmenting the product demand in the country. Moreover, the rising deployment of advanced healthcare facilities for sports clubs and teams is also catalyzing the adoption of PRP-based therapies for treating common injuries in athletes, such as lumbar spine disc pain, rotator cuff injuries, shoulder pain and instability, tennis/golfer’s elbow, etc. Apart from this, the expanding cosmetic surgery sector in the United States is further driving the utilization of PRP-based procedures for improving facial shape and volume. In the coming years, the increasing healthcare expenditures along with the rising demand for non-invasive medical procedures will continue to spur the demand for PRP-based therapies in the United States.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the United States platelet rich plasma market report, along with forecasts at the country and regional level from 2023-2028. Our report has categorized the market based on product type, origin, application and end user.

Breakup by Product Type:

Pure Platelet-Rich Plasma (P-PRP)
Leukocyte- and Platelet-Rich Plasma (LPRP)
Leukocyte- and Platelet-Rich Fibrin (L-PRF)
Pure Platelet-Rich Fibrin (P-PRF)
 

Breakup by Origin:

Autologous PRP
Homologous PRP
Allogeneic PRP
 

Breakup by Application:

Orthopedics
Cosmetic Surgery and Dermatology
Neurosurgery
General Surgery
Cardiothoracic Surgery
Urology
Ophthalmology
Others
 

Breakup by End User:

Hospitals and Clinics
Research Institutes
Others
 

Breakup by Region:

Northeast
Midwest
South
West
 

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Arteriocyte Medical Systems Inc. (Isto Technologies II LLC), Arthrex Inc., Depuy Synthes, Inc. (Johnson & Johnson), Dr Prp USA LLC, EmCyte Corporation, Exactech Inc., Glofinn America LLC (Glofinn Co. Ltd.), Regen Lab USA LLC, Stryker Corporation, Terumo BCT Inc. (Terumo Corporation), ThermoGenesis Holdings Inc. and Zimmer Biomet Holdings Inc.

Key Questions Answered in This Report:

How has the United States platelet rich plasma market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the United States platelet rich plasma market?
What are the key regional markets?
What is the breakup of the market based on the product type?
What is the breakup of the market based on the origin?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the United States platelet rich plasma market and who are the key players?
What is the degree of competition in the industry?


1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
  2.3.1 Primary Sources
  2.3.2 Secondary Sources
2.4 Market Estimation
  2.4.1 Bottom-Up Approach
  2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 United States Platelet Rich Plasma Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product Type
6.1 Pure Platelet-Rich Plasma (P-PRP)
  6.1.1 Market Trends
  6.1.2 Market Forecast
6.2 Leukocyte- and Platelet-Rich Plasma (LPRP)
  6.2.1 Market Trends
  6.2.2 Market Forecast
6.3 Leukocyte- and Platelet-Rich Fibrin (L-PRF) 
  6.3.1 Market Trends
  6.3.2 Market Forecast
6.4 Pure Platelet-Rich Fibrin (P-PRF)
  6.4.1 Market Trends
  6.4.2 Market Forecast
7 Market Breakup by Origin
7.1 Autologous PRP
  7.1.1 Market Trends
  7.1.2 Market Forecast
7.2 Homologous PRP
  7.2.1 Market Trends
  7.2.2 Market Forecast
7.3 Allogeneic PRP
  7.3.1 Market Trends
  7.3.2 Market Forecast
8 Market Breakup by Application
8.1 Orthopedics
  8.1.1 Market Trends
  8.1.2 Market Forecast
8.2 Cosmetic Surgery and Dermatology
  8.2.1 Market Trends
  8.2.2 Market Forecast
8.3 Neurosurgery
  8.3.1 Market Trends
  8.3.2 Market Forecast
8.4 General Surgery
  8.4.1 Market Trends
  8.4.2 Market Forecast
8.5 Cardiothoracic Surgery
  8.5.1 Market Trends
  8.5.2 Market Forecast
8.6 Urology
  8.6.1 Market Trends
  8.6.2 Market Forecast
8.7 Ophthalmology
  8.7.1 Market Trends
  8.7.2 Market Forecast
8.8 Others
  8.8.1 Market Trends
  8.8.2 Market Forecast
9 Market Breakup by End User
9.1 Hospitals and Clinics
  9.1.1 Market Trends
  9.1.2 Market Forecast
9.2 Research Institutes 
  9.2.1 Market Trends
  9.2.2 Market Forecast
9.3 Others
  9.3.1 Market Trends
  9.3.2 Market Forecast
10  Market Breakup by Region
10.1 Northeast
  10.1.1 Market Trends
  10.1.2 Market Forecast
10.2 Midwest
  10.2.1 Market Trends
  10.2.2 Market Forecast
10.3 South
  10.3.1 Market Trends
  10.3.2 Market Forecast
10.4 West
  10.4.1 Market Trends
  10.4.2 Market Forecast
11  SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12  Value Chain Analysis
13  Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14  Price Analysis
15  Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
  15.3.1 Arteriocyte Medical Systems Inc. (Isto Technologies II LLC)
   15.3.1.1 Company Overview
   15.3.1.2 Product Portfolio 
   15.3.1.3 SWOT Analysis
  15.3.2 Arthrex Inc.
   15.3.2.1 Company Overview
   15.3.2.2 Product Portfolio 
  15.3.3 Depuy Synthes Inc. (Johnson & Johnson)
   15.3.3.1 Company Overview
   15.3.3.2 Product Portfolio 
   15.3.3.3 Financials
  15.3.4 Dr Prp USA LLC
   15.3.4.1 Company Overview
   15.3.4.2 Product Portfolio 
  15.3.5 EmCyte Corporation
   15.3.5.1 Company Overview
   15.3.5.2 Product Portfolio 
  15.3.6 Exactech Inc.
   15.3.6.1 Company Overview
   15.3.6.2 Product Portfolio 
  15.3.7 Glofinn America LLC (Glofinn Co. Ltd.)
   15.3.7.1 Company Overview
   15.3.7.2 Product Portfolio 
  15.3.8 Regen Lab USA LLC
   15.3.8.1 Company Overview
   15.3.8.2 Product Portfolio 
  15.3.9 Stryker Corporation
   15.3.9.1 Company Overview
   15.3.9.2 Product Portfolio 
   15.3.9.3 Financials
   15.3.9.4 SWOT Analysis
  15.3.10 Terumo BCT Inc. (Terumo Corporation)
   15.3.10.1 Company Overview
   15.3.10.2 Product Portfolio 
   15.3.10.3 Financials
   15.3.10.4 SWOT Analysis
  15.3.11 ThermoGenesis Holdings Inc.
   15.3.11.1 Company Overview
   15.3.11.2 Product Portfolio 
   15.3.11.3 Financials
   15.3.11.4 SWOT Analysis
  15.3.12 Zimmer Biomet Holdings Inc.
   15.3.12.1 Company Overview
   15.3.12.2 Product Portfolio 
   15.3.12.3 Financials
   15.3.12.4 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings